EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Small Molecule–Drug Conjugates Emerge as a New Promising Approach for Cancer Treatment

Tiansi Wang, Meichai Li, Ruting Wei, Xinyu Wang, Zhizhe Lin, Jianming Chen, Xin Wu

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.3c01049 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Tiansi Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Fujian University of Traditional Chinese Medicine, No. 1, Qiuyang Road, Fuzhou, Fujian 350122, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Immunoconjugates, Neoplasms. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Science and Technology Project of Little Giant, Shanghai Qingpu District Industry-University-Research Cooperative Development Funding Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibody drug conjugates (ADCs) have emerged as a new promising class of anti- cancer agents. However, limitations such as higher costs and unavoidable immunogenicity due to their relatively large structures cannot be ignored. Therefore, the development of lightweight drugs such as small molecule-drug conjugates (SMDCs) based on the ADC design idea has become a new option for targeted therapy. SMDCs are derived from the coupling of small-molecule targeting ligands with cytotoxic drugs. They are composed of three parts: small-molecule targeting ligands, cytotoxic molecules, and linkers. Compared with ADCs, SMDCs can be more rapidly and evenly dispersed into tumor tissues, with low cost and no immunogenicity. In this article, we will give a comprehensive review of different types of SMDCs currently under clinical trials to provide ideas and inspirations for the development of clinically applicable SMDCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsImmunoconjugatesNeoplasmsAntigens

Stichwörter der Autor:innen

cancerconjugateslinkersmall molecule−drug conjugatestarget treatment

Substanzen

Antineoplastic AgentsImmunoconjugatesAntigens

Autor:innen und Institutionen

  • Fujian University of Traditional Chinese Medicine, No. 1, Qiuyang Road, Fuzhou, Fujian 350122, China.
  • Shanghai Wei Er Lab, Shanghai 201799, China.
  • Shandong University of Traditional Chinese Medicine, No.4655, University Road, Jinan, Shandong 250355, China.

Förderung

  • National Natural Science Foundation of China
  • Shanghai Science and Technology Project of Little Giant
  • Shanghai Qingpu District Industry-University-Research Cooperative Development Funding Project
  • Jiaxing Key Laboratory of Oncological Photodynamic Therapy and Targeted Drug Research

Zitieren

APA

Wang, T., Li, M., Wei, R., Wang, X., Lin, Z., Chen, J., & Wu, X. (2024). Small Molecule–Drug Conjugates Emerge as a New Promising Approach for Cancer Treatment. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c01049

Vancouver

Wang T, Li M, Wei R, Wang X, Lin Z, Chen J, et al. Small Molecule–Drug Conjugates Emerge as a New Promising Approach for Cancer Treatment. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.3c01049

BibTeX
@article{Wang2024,
  author = {Wang, Tiansi and Li, Meichai and Wei, Ruting and Wang, Xinyu and Lin, Zhizhe and Chen, Jianming and Wu, Xin},
  title = {Small Molecule–Drug Conjugates Emerge as a New Promising Approach for Cancer Treatment},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.3c01049}
}
Kostenlos starten →